These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18193497)

  • 1. Directly administered antiretroviral therapy for HIV-infected drug users does not have an impact on antiretroviral resistance: results from a randomized controlled trial.
    Maru DS; Kozal MJ; Bruce RD; Springer SA; Altice FL
    J Acquir Immune Defic Syndr; 2007 Dec; 46(5):555-63. PubMed ID: 18193497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trial.
    Maru DS; Bruce RD; Walton M; Springer SA; Altice FL
    J Acquir Immune Defic Syndr; 2009 Feb; 50(2):176-81. PubMed ID: 19131891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial.
    Altice FL; Maru DS; Bruce RD; Springer SA; Friedland GH
    Clin Infect Dis; 2007 Sep; 45(6):770-8. PubMed ID: 17712763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-infected drug users.
    Smith-Rohrberg D; Mezger J; Walton M; Bruce RD; Altice FL
    J Acquir Immune Defic Syndr; 2006 Dec; 43 Suppl 1():S48-53. PubMed ID: 17133204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication.
    Altice FL; Mezger JA; Hodges J; Bruce RD; Marinovich A; Walton M; Springer SA; Friedland GH
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S376-87. PubMed ID: 15156426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Directly administered antiretroviral therapy for HIV-infected individuals in opioid treatment programs: results from a randomized clinical trial.
    Lucas GM; Mullen BA; Galai N; Moore RD; Cook K; McCaul ME; Glass S; Oursler KK; Rand C
    PLoS One; 2013; 8(7):e68286. PubMed ID: 23874575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study design and participant characteristics of a randomized controlled trial of directly administered antiretroviral therapy in opioid treatment programs.
    Mullen BA; Cook K; Moore RD; Rand C; Galai N; McCaul ME; Glass S; Oursler KK; Lucas GM
    BMC Infect Dis; 2011 Feb; 11():45. PubMed ID: 21324133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy.
    Maru DS; Bruce RD; Walton M; Mezger JA; Springer SA; Shield D; Altice FL
    AIDS Behav; 2008 Mar; 12(2):284-93. PubMed ID: 18085432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community - a potential conduit to improved HIV treatment outcomes.
    Saber-Tehrani AS; Springer SA; Qiu J; Herme M; Wickersham J; Altice FL
    Contemp Clin Trials; 2012 Mar; 33(2):436-44. PubMed ID: 22101218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting candidates for directly administered highly active antiretroviral therapy: benefits observed in HIV-infected injecting drug users in residential drug-rehabilitation facilities.
    Babudieri S; Dorrucci M; Boschini A; Carbonara S; Longo B; Monarca R; Ortu F; Congedo P; Soddu A; Maida IR; Caselli F; Madeddu G; Rezza G
    AIDS Patient Care STDS; 2011 Jun; 25(6):359-64. PubMed ID: 21612546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States.
    Ross LL; Shortino D; Shaefer MS
    AIDS Res Hum Retroviruses; 2018 Aug; 34(8):672-679. PubMed ID: 29732898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy.
    Lucas GM; Mullen BA; McCaul ME; Weidle PJ; Hader S; Moore RD
    AIDS Patient Care STDS; 2007 Aug; 21(8):564-74. PubMed ID: 17711381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study.
    Lucas GM; Weidle PJ; Hader S; Moore RD
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S409-13. PubMed ID: 15156431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directly observed antiretroviral therapy in substance abusers receiving methadone maintenance therapy does not cause increased drug resistance.
    Brust JC; Litwin AH; Berg KM; Li X; Heo M; Arnsten JH
    AIDS Res Hum Retroviruses; 2011 May; 27(5):535-41. PubMed ID: 20854173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden?
    Lucas GM; Flexner CW; Moore RD
    AIDS Patient Care STDS; 2002 Nov; 16(11):527-35. PubMed ID: 12513901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved prediction of salvage antiretroviral therapy outcomes using ultrasensitive HIV-1 drug resistance testing.
    Pou C; Noguera-Julian M; Pérez-Álvarez S; García F; Delgado R; Dalmau D; Álvarez-Tejado M; Gonzalez D; Sayada C; Chueca N; Pulido F; Ibáñez L; Rodríguez C; Casadellà M; Santos JR; Ruiz L; Clotet B; Paredes R
    Clin Infect Dis; 2014 Aug; 59(4):578-88. PubMed ID: 24879788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Resistance Mutation Frequency of Single-Genome Amplification-Derived HIV-1 Polymerase Genomes in the Cerebrospinal Fluid and Plasma of HIV-1-Infected Individuals under Nonsuppressive Therapy.
    St Bernard L; Abolade J; Mohri H; Markowitz M; Evering TH
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32759323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-resistance mutations number and K70R or T215Y/F substitutions predict treatment resumption during guided treatment interruptions.
    Darwich L; Esteve A; Ruiz L; Paredes R; Bellido R; Cabrera C; Romeu J; Bofill M; Clotet B; Martinez-Picado J
    AIDS Res Hum Retroviruses; 2008 May; 24(5):725-32. PubMed ID: 18462084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does directly administered antiretroviral therapy represent good value for money in sub-Saharan Africa? A cost-utility and value of information analysis.
    Uthman RT; Sutton AJ; Jackson LJ; Uthman OA
    PLoS One; 2018; 13(1):e0191465. PubMed ID: 29360841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.